CAS 2411853-34-2

JR-AB2-011

CAS : 2411853-34-2

JR-AB2-011

Degré de pureté : ≥98%

Masse moléculaire : 398.28g/mol

Ref: 54-BUP05565

Jr-ab2-011

CAS : 2411853-34-2

Jr-ab2-011 is an analog of glimepiride, a medication used to treat diabetes. It has been shown to inhibit the activity of kinases in human urine and may have potential as an anticancer agent. Jr-ab2-011 has been found to induce apoptosis in cancer cells and may be effective against a variety of tumors, including Chinese hamster ovary (CHO) cells. Additionally, Jr-ab2-011 has demonstrated inhibitory effects on the growth of cancer cells when combined with other inhibitors such as apomorphine and nintedanib. Its potential as a therapeutic agent for cancer treatment is currently being investigated.

Formule : C₁₇H₁₄Cl₂FN₃OS

Degré de pureté : Min. 95%

Masse moléculaire : 398.3 g/mol

Ref: 3D-LWD85334

JR-AB2-011

CAS : 2411853-34-2

JR-AB2-011: selective mTORC2 inhibitor, IC50 = 0.36μM, blocks Rictor-mTOR, Ki = 0.19μM, cytotoxic in glioblastoma.

Formule : C₁₇H₁₄Cl₂FN₃OS

Degré de pureté : 98.33% - 98.33%

Couleur et forme : Solid

Masse moléculaire : 398.28

Ref: TM-T11728